Tsugiko Oze

Post-treatment Levels of α-Fetoprotein Predict Incidence of Hepatocellular Carcinoma After Interferon Therapy

Tsugiko Oze, Naoki Hiramatsu, Takayuki Yakushijin et al. · Clinical Gastroenterology and Hepatology · 2013 · 105 citations · Full text

Post-treatment Levels, Hepatology, Medicine +12

Suppression of hepatocellular carcinoma development in hepatitis <scp>C</scp> patients given interferon‐based antiviral therapy

Naoki Hiramatsu, Tsugiko Oze, Tetsuo Takehara · Hepatology Research · 2014 · 79 citations · Full text

Immunology, Pathology, Chronic Hepatitis C +23

Ribavirin dose reduction raises relapse rate dose‐dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha‐2b plus ribavirin

Naoki Hiramatsu, Tsugiko Oze, Takayuki Yakushijin et al. · Journal of Viral Hepatitis · 2009 · 69 citations

Hepatology, Hepatitis C, Ribavirin Exposure +15

Liver stiffness measurement by acoustic radiation force impulse is useful in predicting the presence of esophageal varices or high-risk esophageal varices among patients with HCV-related cirrhosis

Naoki Morishita, Naoki Hiramatsu, Tsugiko Oze et al. · Journal of Gastroenterology · 2013 · 60 citations

Medical Ultrasound, Hepatology, Liver Stiffness Measurement +9

Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection

Mika Kurokawa, Naoki Hiramatsu, Tsugiko Oze et al. · Journal of Gastroenterology · 2012 · 59 citations

Hepatitis D, Long-term Effect, Oncology +10